Cantel Medical (CMD) Tops Q2 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts CMD Hot Sheet
Join SI Premium – FREE
Cantel Medical (NYSE: CMD) reported Q2 EPS of $0.52, $0.04 better than the analyst estimate of $0.48. Revenue for the quarter came in at $184.82 million versus the consensus estimate of $188.04 million.
For earnings history and earnings-related data on Cantel Medical (CMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Latham Group, Inc. (SWIM) Misses Q3 EPS by 5c ; Offers Guidance
- Essential Utilities, Inc. (WTRG) Tops Q3 EPS by 4c
- Bowhead Specialty Holdings (BOW) Tops Q3 EPS by 54c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
